news

Pushing the immune system to eat cancer

Researchers have found a way to activate macrophages that have been forced to help cancer grow and spread around the body…

cancer

Researchers have managed to find a way to fuel macrophages with the energy needed to attack and eat cancer cells.

Macrophages are immune cells that engulf foreign objects and destroy them, and as such are supposed to ‘serve and protect’. However, cancer has managed to find a way around them. It is known that macrophages are able to support the growth of cancer, and its spread around the body, or inhibit  its action. Tumours are also able to express a signal called CD47, which is able to lull macrophages into a deep sleep, preventing them from ‘eating’.

Scientists at the Abramson Cancer Center at the University of Pennsylvania found that rewiring the metabolism of the macrophage could overcome this signal, acting like an alarm clock, rousing and preparing the cells for ‘work’.

 

Reserve your FREE place

 


Are low affinity or poor TCR yields slowing you down?

Explore how CHO expression of soluble TCRs and TCR affinity maturation workflows via phage, serving as essential building blocks for early-stage TCR-TCE candidate generation.

22 October 2025 | 16:00 PM BST | FREE Webinar

Join Jiansheng Wu, Ph.D. to explore two integrated strategies:

  • High-titer CHO-based expression of sTCRs (~100 mg/L), enabling scalable and high-throughput production
  • Optimized phage display affinity maturation, improving TCR binding by up to ~10,000-fold

Whether you’re starting a new TCR program or optimizing an existing platform, this session will offer actionable strategies to accelerate discovery and improve candidate quality.

Register Now – It’s Free!

 

In cancer, macrophages are the most prominent immune cells but are often coaxed by the cancer to help it grow and spread. The researchers mentioned how blocking inhibitory signals like CD47 is not always sufficient enough to convince the macrophages to attack the cancer. 

Dr Gregory L. Beatty, an Assistant Professor of Hematology-Oncology at Penn’s Perelman School of Medicine said: “It turns out macrophages need to be primed before they can go to work, which explains why solid tumors may resist treatment with CD47 inhibitors alone.”

The team activated the macrophages with CpG – a receptor that can send the initial signal, and found that this rapidly induced tumour shrinkage, prolonging the survival of the mice – even without the use of T-cells.

They also found that these activated macrophages were able to eat cancer cells even in the presence of high levels of CD47.

“Cancer does not shrink without the help of macrophages and macrophages need the right fuel to eat cancer cells and shrink tumors,” Dr Jason Mingen Liu, the study’s lead author said. “To do this, a shift in metabolism is needed to steer the energy in the right direction. It is the metabolism that ultimately allows macrophages to override signals telling them not to do their job.”

The study was published in the journal Nature Immunology.

Leave a Reply

Your email address will not be published. Required fields are marked *